Top Companies in the E-clinical Trials Market with Recent Innovation

- Medidata Solutions (Dassault Systèmes)
- Oracle Health Sciences
- Veeva Systems
- Parexel International
- IQVIA
- Signant Health
- eClinicalWorks
- Clario (ERT)
- Castor EDC
- ArisGlobal
- Medrio
- Anju Software
- Bioclinica
- DataTrak International
- MedNet Solutions
- Florence Healthcare
- OpenClinica
- ClinOne
- Verge HealthTech
- TrialSpark
Market Forecast
The global e-clinical trials market size is estimated at US$ 612 million in 2024, is projected to grow to US$ 645.9 million in 2025, and is expected to reach around US$ 1046.05 million by 2034. The market is projected to expand at a CAGR of 5.54% between 2025 and 2034.
E-Clinical Trials Market-Value Chain Analysis
R&D
R&D processes include electronic systems that have been applied for e-clinical trial implementation procedures, like randomization and data entry.
Key Players: Syneos Health, Labcorp, and Medpace
Clinical Trials Conducting Processes
e-Clinical trials involve the application of electronic systems for the management of data, monitoring of patients, and study design to increase efficiency and speed in the clinical trial technology, which includes phases of planning, implementation, patient recruitment, and analysis of data.
Key Players: Medidata, Oracle, and Veeva Systems
Patient Support and Services
e-Clinical trials provide never-ending patient services, including the direct collection of clinical research data by electronic data collection or e-CRF, internet-driven study clinical laboratory services, and departmental supportive systems.
Key Players: IQVIA, Parexel, and ICON
Latest Announcements by Industry Leaders
In September 2025, Barry Lake, co-founder and president, RealTime-Devana, stated, Sponsors and CROs finally have access to the right data at the right time - patient screening and enrollment trends, feasibility turnaround times, contract execution speeds, and more.
Recent Developments in the E-Clinical Trials Market
- In December 2023, Sitero and CRIO launched a strategic partnership to lift the administrative burden of clinical research for sites and sponsors while improving patient safety, experience, and outcomes. The partnership revolutionizes trial execution by removing the need for manual, redundant, and error-prone activities across the clinical lifecycle. By leveraging the proprietary technology platform of CRIO and the deep Clinical expertise of Sitero, the technology-enabled service provides a next-generation delivery model that manages key tasks such as monitoring, study startup, enrollment, data management, and recruitment remotely and fully electronically.
- In September 2025, RealTime eClinical Solutions announces the launch of TrialAlign, a groundbreaking site selection, feasibility, and performance analytics platform designed to help sponsors and CROs make smarter, more accurate clinical trial placement decisions.
- In August 2025, Eisai Co., Ltd. and Biogen Inc. announced that the anti-amyloid beta (Aβ) monoclonal antibody LEQEMBI has been launched in Austria and will be launched in Germany. LEQEMBI received the European Commission (EC) approval as the first therapy that targets an underlying cause of Alzheimers disease (AD).
Become a valued research partner with us, please feel free to contact us at sales@towardshealthcare.com